Hiroki Shimizu

Dr. Hiroki Shimizu

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
AFAdrian M. D. Falconer
Adrian M. D. Falconer
CCChun Ming Chan
Chun Ming Chan
JGJoseph Gray
Joseph Gray
INIzuru Nagashima
Izuru Nagashima
RHRobert A. Holland
Robert A. Holland
DWDavid J. Wilkinson
David J. Wilkinson
The collagenase subfamily of matrix metalloproteinases (MMPs) have important roles in the remodeling of collagenous matrices. The proteinase-activated receptor (PAR) family has a unique mechanism of activation requiring proteolysis of an extracellular domain forming a neo-N terminus that acts as a tethered ligand, a process that has been associated with the development of arthritis. Canonical PAR2 activation typically occurs via a serine proteinase at Arg36-Ser37, but other proteinases can cleave PARs downstream of the tethered ligand and “disarm” the receptor. To identify additional cleavage sites within PAR2, we synthesized a 42-amino-acid peptide corresponding to the extracellular region. We observed that all three soluble MMP collagenases, MMP-1, MMP-8, and MMP-13, cleave PAR2 and discovered a novel cleavage site (Ser37-Leu38). Metalloproteinases from resorbing bovine nasal cartilage and recombinant human collagenases could cleave a quenched fluorescent peptide mimicking the canonical PAR2 activation region, and kinetic constants were determined. In PAR2-overexpressing SW1353 chondrocytes, we demonstrated that the activator peptide SLIGKV-NH2 induces rapid calcium flux, inflammatory gene expression (including MMP1 and MMP13), and the phosphorylation of extracellular signal-regulated kinase (ERK) and p38 kinase. The corresponding MMP cleavage-derived peptide (LIGKVD-NH2) exhibited no canonical activation; however, we observed phosphorylation of ERK, providing evidence of biased agonism. Importantly, we demonstrated that preincubation with active MMP-1 reduced downstream PAR2 activation by a canonical activator, matriptase, but not SLIGKV-NH2. These results support a role for collagenases as proteinases capable of disarming PAR2, revealing a mechanism that suppresses PAR2-mediated inflammatory responses.

1 May 2000 in Nuclear Physics A
Verified
Journal Article
Closed access
TNT. Nakano
T. Nakano
JAJ.K. Ahn
J.K. Ahn
Hiroyasu EjiriHiroyasu Ejiri
Hiroyasu Ejiri
MFMakoto Fujiwara
Makoto Fujiwara
THT. Hotta
T. Hotta
HSHiroki Shimizu
Hiroki Shimizu

29 April 2014 in Bioscience, Biotechnology, and Biochemistry
Verified
Journal Article
Closed access
INIzuru Nagashima
Izuru Nagashima
JSJun-ichi Sugiyama
Jun-ichi Sugiyama
TSTomomi Sakuta
Tomomi Sakuta
MSMasahide Sasaki
Masahide Sasaki
HSHiroki Shimizu
Hiroki Shimizu
Microwave irradiation at different frequencies gave unique results for the hydrolyses of glycosyl bonds by β-Glucosidase HT1. With the observed relative complex permittivity data for the reaction buffer, 2.45 GHz microwave radiation affected both waters and ions, while 5.80 GHz only affected waters. We, here, propose that would be one of the unique “microwave nonthermal effects”.

3 January 2011 in Organic Chemistry International
Verified
Journal Article
Open access
PDF file
SGSantosh L. Gaonkar
Santosh L. Gaonkar
INIzuru Nagashima
Izuru Nagashima
HSHiroki Shimizu
Hiroki Shimizu
A new series of 2-{4-[2-(N-methyl-2-pyridylamino)ethoxy]phenyl}-5-substituted 1,3,4-oxadiazoles were synthesized by the oxidative cyclization of hydrazones derived from 4-[2-(methylpyridin-2-ylamino)ethoxy]benzaldehyde and aryl hydrazines using chloramine-T as an efficient catalyst. All steps were assisted by microwave irradiation. Microwave enables all these reactions to be simple, rapid, high yielding, and avoid chromatograph purification and led environmentally benign total synthesis of focused oxadiazole library. All the synthesized compounds were isolated in good yield and characterized by 1H NMR, 13C NMR, and elemental analyses. The title compounds represent a novel class of biologically active heterocycles.

Verified
Journal Article
Open access
PDF file
RKRyoka Kokubu
Ryoka Kokubu
SOshiho ohno
shiho ohno
HKHirohide Kuratani
Hirohide Kuratani
YTYuka Takahashi
Yuka Takahashi
NMNoriyoshi Manabe
Noriyoshi Manabe
YYYoshiki Yamaguchi
Yoshiki Yamaguchi
Anti-mucin1 (MUC1) antibodies have been widely used for breast cancer diagnosis and treatment. This is based on the fact that MUC1 undergoes aberrant glycosylation upon cancer progression, and anti-MUC1 antibodies differentiate changes in glycan structure. MY.1E12 is a promising anti-MUC1 antibody with a distinct specificity toward MUC1 modified with an immature O-glycan (NeuAcα(2-3)Galβ(1-3)GalNAc) on a specific Thr. However, the structural basis for the interaction between MY.1E12 and MUC1 remains unclear. The aim of this study is to elucidate the mode of interaction between MY.1E12 and MUC1 O-glycopeptide by NMR, molecular dynamics (MD) and docking simulations. NMR titration using MUC1 O-glycopeptides suggests that the epitope is located within the O-linked glycan and near the O-glycosylation site. MD simulations of MUC1 glycopeptide showed that the O-glycosylation significantly limits the flexibility of the peptide backbone and side chain of the O-glycosylated Thr. Docking simulations using modeled MY.1E12 Fv and MUC1 O-glycopeptide, suggest that VH mainly contributes to the recognition of the MUC1 peptide portion while VL mainly binds to the O-glycan part. The VH/VL-shared recognition mode of this antibody may be used as a template for the rational design and development of anti-glycopeptide antibodies.

19 June 2012 in Carbohydrate Research
Verified
Journal Article
Closed access
INIzuru Nagashima
Izuru Nagashima
TMToshiki Mine
Toshiki Mine
TYTakeshi Yamamoto
Takeshi Yamamoto
HSHiroki Shimizu
Hiroki Shimizu